What happened
Shares of Moderna (NASDAQ:MRNA) jumped 7.8% to a record closing high of $348.83 on Friday after European health officials recommended authorizing the drugmaker’s coronavirus vaccine for kids 12 and older.
So what
The European Medicines Agency’s…
